Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Peripheral pancytopenia].

S A Bello-González1, A Bergés-García

  • 1Depto. de Investigaciones Hematológicas, Hospital Infantil de México Federico Gómez, México, D.F.

Boletin Medico Del Hospital Infantil De Mexico
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Haemophilic arthropathy: the usefulness of intra-articular oxytetracycline (synoviorthesis) in the treatment of chronic synovitis in children.

Haemophilia : the official journal of the World Federation of Hemophilia·2010
Same author

[Hematologic considerations in the dental management of the pregnant woman].

Practica odontologica·1988
Same author

[Hemoglobin E (26 Glu-Lys) and beta-thalassemia in a Mexican family].

Boletin medico del Hospital Infantil de Mexico·1984

Peripheral pancytopenia, a syndrome with early diagnostic potential, can be categorized into three main groups: non-neoplastic, neoplastic, and neoplasms with similar presentations. This classification aids in understanding diverse underlying pathologies.

Area of Science:

  • Hematology
  • Pathology

Context:

  • Peripheral pancytopenia presents a diagnostic challenge due to its diverse etiology.
  • Early identification is crucial for effective management of pancytopenia.

Purpose:

  • To classify the pathological entities associated with peripheral pancytopenia.
  • To provide a structured approach for diagnosing pancytopenia.

Summary:

  • Peripheral pancytopenia is classified into three groups: non-neoplastic (aplastic anemia, infections, autoimmune diseases, nutritional deficiencies), neoplastic (leukemias, lymphomas, other cancers), and neoplasms with similar features.
  • This categorization aids in differentiating between various causes of pancytopenia, facilitating targeted diagnosis and treatment.

Impact:

Related Experiment Videos

  • Enhances the diagnostic framework for peripheral pancytopenia.
  • Supports clinicians in identifying the underlying cause of pancytopenia for improved patient outcomes.